The Modi government has asked pharmaceutical companies in the country to start preparing for the third wave of COVID-19 and stock up key drugs in a span of the next two-three months. #COVID19
newsbytesapp.com/news/india/pre…
The Department of Pharmaceuticals, India’s drug regulator, held a meeting in this regard on Tuesday. The Indian Drug Manufacturers Association, the Federation of Pharma Entrepreneurs, and the Bulk Drug Manufacturers Association were present in the meeting. #CoronaSecondWave
In the meeting, the Department of Pharmaceuticals directed pharmaceutical companies to increase the production of the antiviral drug Remdesivir, which is being widely used to treat COVID-19 patients across India. #Remedisivir
Reportedly, the government is also looking to discuss with patent-holding companies such as Gilead if they can allow voluntary licensing of Remdesivir to Indian manufacturers for the time being. #India #COVID19
Meanwhile, pharmaceutical companies across India are now boosting their production of the antifungal drug Amphotericin B in view of the rising Black fungus cases. However, it would take at least 15-30 days for the fresh produce to enter the market. #BlackFungus #CoronavirusIndia
To note, India registered 2.67 lakh fresh infections and 4,529 fatalities - its highest daily death toll in the pandemic in the last 24 hours. However, only 3% of India's population remains fully vaccinated. #COVID19 #CoronaPandemic
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.